Myriad Genetics Announces Reorganization of European Operations and Sale of EndoPredict Business – Read more
Industry-leading accuracy so you can feel confident in your results.
Myriad Genetics protects your personal information.
Clear, actionable results, and support along the way.
A prognostic and predictive test to guide ER+, HER2-, N0 and N+ breast cancer treatment decisions
The most comprehensive HRD tumor test to guide PARP inhibitor treatment
A Gene Expression Test to stratify patients according to Prostate Cancer Aggressiveness
A multi-gene panel that helps to determine a patient’s risk by evaluating a number of hereditary cancer syndromes, with focus on 11 primary cancer sites.